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1. Introduction
The use of proteins for therapeutic applications has increased dramatically in the last several
decades. There has been a tremendous increase in the number of approved drugs derived
from recombinant proteins and monoclonal antibodies since the approval of recombinant
insulin in 1982 (Figure 1).1 In addition, the number of approved indications is almost four
times the number of approved drugs in 2005. Sales of protein drugs in 2008 are estimated to
be around 71 billion USD.2 Thus, many proteins are currently being investigated for use as
therapeutic agents for different diseases (i.e., cancer, autoimmune diseases). Their
development as potential drugs, however, has been hampered by difficulties in formulating
them into therapeutic agents with long shelf lives. Most proteins are physically and
chemically unstable. This instability is a major barrier for researchers in developing stable
therapeutic products. Factors that influence the stability of a protein can be divided into two
categories: (1) intrinsic factors derived from the inherent physicochemical properties of the
protein (e.g., primary, secondary, tertiary, and quaternary structures) and (2) the extrinsic
factors derived from the environment of the protein such as pH, temperature, buffer, ionic
strength, and excipients. Because physical degradation (e.g., conformational changes,
aggregation and precipitation, etc) is one of the major problems in formulating protein
therapeutics, many studies have been done to elucidate factors that influence physical
stability of proteins. Recently, Middaugh et al. developed an empirical phase diagram based
approach for the rapid evaluation of protein physical stability.3–5 The chemical degradation
of proteins seen in some amino acids (i.e., Asn, Asp, and Met) has been extensively studied
and reviewed.6–15 On the other hand, the effect of other amino acids such as Cysteine and
Cystine on the physical and chemical stability of proteins has not been extensively reviewed.
Thus, this review focuses on the role of Cys residue in the structure and stability of proteins.
Different types of proteins such as antibodies, receptors, hormones, and enzymes often
contain one or more Cys residues, and these may be involved in the formation of intra- and
inter-molecular disulfide bond(s) or they may exist as free thiols. In some enzymes, the free
Cys residue is part of the catalytic activity site. The presence of a disulfide bond in peptides
and proteins has been shown to impose conformational rigidity on a protein. The disulfide
bond can have either a left- or a right- handed spiral conformation with a dihedral angle of
+90 or −90 degrees, respectively. In a disulfide bond, the most common Chi–1 angle of the
Cys residue is −60 degrees with a 5.2–6.1 Å distance between the Cαs of Cys residues.16
During the folding process, the formation of non-native intramolecular disulfide bond(s)
may cause protein misfolding, which may lead to aggregation and precipitation.
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Native disulfide bonds in proteins are assembled during the oxidative folding process. In
eukaryotes, this process occurs in the endoplasmic reticulum (ER) lumen,17 whereas in
prokaryotes it takes place in the periplasm.18 Thus, disulfide bonds are only formed in
specific cellular compartments. Proteins synthesized by ribosomes are in reduced and
unfolded form, and their oxidative refolding in eukaryotes is aided by a series of enzymes
such as the endopasmic reticulum oxireductin-1 (Ero1), protein disulfide isomerases (PDI)
and Erv2.17,19–21 Many of these enzymes possess C-X-X-C (i.e., PDI) and C-X-C (i.e.,
Erv2) motifs that are involved in thiol-disulfide redox exchange reactions.22 PDI directly
oxidizes thiol groups in a protein via a series of thiol-disulfide exchange reactions by
partnering with Ero1 or Erv2. The Ero1 enzyme, which is found inside the ER and is
associated with the ER membrane, oxidizes PDI to form an Ero1-PDI mixed disulfide form.
If the disulfide bond in the protein substrate is incorrectly formed, PDI catalyzes the
reduction of these disulfide bonds and, subsequently, re-oxidizes the protein substrate to
form the native disulfide bond. Thus, as a general rule, cytoplasmic proteins contain free
thiols, while proteins in other compartments such as the ER can possess disulfide bonds. An
exception to this rule is a family of thermophilic organisms which has been discovered to
produce intracellular proteins with disulfide bonds. This is presumably due to the presence
of protein disulfide oxidoreductase (PDO) in their cytoplasm, which oxidizes the cysteines
to disulfides within intracellular proteins.23
In bacterial cells, the oxidative folding machinery parallels the machinery in mammalian
cells, and the oxidation reaction is catalyzed by the enzymes DsbA, DsbB, DsbC and
DsbD.18 The disulfide bond A (DsbA) enzyme oxidizes thiol groups of the substrate protein
to a disulfide bond in the periplasm with the simultaneous reduction of its own disulfide
bond. Then, the reduced DsbA is reoxidized by DsbB. The oxidized state of DsbB is
maintained by transferring electrons to ubiquinones (benzoquinone derivatives) and
menaquinones (naphthoquinone derivatives), components of the respiratory electron
transport chain system. When the substrate protein forms a non-native disulfide bond, DsbC
enzyme reduces the non-native disulfides. This is followed by the subsequent re-oxidation of
the substrate to form the native disulfide by DsbA or DsbC. Finally, DsbD functions to keep
DsbC in the reduced state, and the oxidized DsbD can be reduced by cytoplasmic
thioredoxin.
2. Disulfide Bond Formation
Prior to the formation of a disulfide bond, the protein may or may not be folded into a
native-like structure with the Cys residues in a favorable position to form a disulfide
bond.24,25 In the case of bovine pancreatic trypsin inhibitor (BPTI), the formation of all
three disulfide bonds in BPTI occurs via stable intermediates with a native conformation
containing one or two native disulfide bonds.24,25 No significant amount of non-native
disulfide intermediates was observed. However, the formation of only native-like
intermediates is not always the case; for example, hirudin, with three disulfide bonds,
undergoes oxidative folding via heterogeneous intermediates with two or three non-native
disulfide bonds.26 These scrambled disulfide bonds undergo reduction followed by oxidative
rearrangement to form the native protein structure. The reductive unfolding of this protein
follows a pathway similar to that of the folding process, but reversed. The in vitro oxidative
folding of human macrophage colony stimulating factor β (rhm-CSFβ) follows a pathway
similar to that of hirudin. The rhm-CSFβ protein is a dimer with three intermolecular
disulfide bonds between the two monomers. Each monomer also contains three
intramolecular disulfide bonds.27 The oxidative folding of rhm-CSFβ involves the formation
of monomeric isomers with native and non-native intramolecular disulfide bonds; the
monomer isomerization step is the rate-determining step in this process.27 Upon disulfide
shuffling, the protein forms a stable dimeric intermediate that possesses all of the
Trivedi et al. Page 2













intramolecular disulfides, including a non-native intermolecular disulfide bond.
Rearrangement of the non-native disulfide bond creates the native oxidized rhm-CSFβ.
Although the oxidative folding of different proteins could take different pathways, the
process normally adheres to some general rules. Disulfide bond formation is usually favored
at basic pH, and the presence of an oxidizing agent such as oxidized glutathione increases
the rate of oxidative folding, whereas the presence of denaturants such as urea or guanidine
hydrochloride (Gdn.HCl) hampers the folding process. These rules do not apply, however,
to the oxidative folding of murine prion protein (mPrP 23–231), which has only one
intramolecular disulfide bond at Cys179–Cys214.28 The formation of a disulfide bond in
reduced mPrP is very slow at pH 8.0 in the absence of denaturant, but mPrP refolds properly
in the presence of a denaturant and glutathione at pH 8.0.28 Contrary to intuition, the best
pH condition to form a disulfide in mPrP is 4–5. This observation can be explained by the
fact that, at alkaline and neutral pH, the reduced and unfolded mPrP is present in a stable
intermediate conformation with its Cys residues buried and separated from each other. The
addition of glutathione, therefore, does not facilitate oxidation of Cys. The addition of
denaturant and a pH of 4.0 facilitate the unfolding of the stable intermediate, bringing the
two Cys residues closer and allowing them to form a disulfide bond.
3. Effects of disulfide bond on protein stability
Intramolecular disulfide bonds are known to contribute to protein thermal stability.
Reducing all five disulfide bonds inactivates the Aspergillus niger phytase due to
conformational change and/or unfolding.29 Another example of the effect of disulfide bonds
on stability is observed in the soybean Bowman-Birk inhibitor (BBI). The crystal structure
of BBI has a bow-tie motif, with a trypsin-binding loop at one end and a chymotrypsin-
binding loop at the other. In contrast to most globular proteins, it has exposed hydrophobic
patches and charged residues containing bound water molecules in its interior.30,31
Interestingly, BBI is remarkably stable against heat and chemical denaturants; this stability
can be attributed to the seven intramolecular disulfide bonds within the protein’s structure
that “lock” it in its native conformation.30
Introduction of a disulfide bond by Cys mutation has been shown to improve the physical
stability of some proteins. In case of Subtilisin E, mutations of Gly61Cys and Ser98Cys
followed by the formation of the Cys61–Cys98 disulfide produce an active enzyme with a
4.5 °C increase in melting temperature and a half-life three times longer than that of the
native protein.32 In addition, there was no change in its enzymatic activity due to the
engineered disulfide bond. Similarly, a Cys39–Cys85 disulfide bond was engineered into
dihydrofolate reductase (DHFR) without a significant alteration in its conformation. The
disulfide mutant had an improved stability with its ΔG° higher than that of the native protein
by 1.8 kcal/mol.33
At this point, it is necessary to discuss the thermodynamics behind the stabilizing effect of
disulfide bonds on proteins. This stabilizing effect of disulfides is manifested by an increase
in the melting point of the protein. The melting or unfolding transition of a protein is
generally regarded as a reversible process between the native and the unfolded states. The
differential scanning calorimetry (DSC) is usually employed to determine the reversible
thermal unfolding of a protein. Superimposable DSC themorgrams resulted from repeated
scans of the same protein imply a two-state reversible unfolding process, which is depicted
as N ⇄ U, where N represents the native state and U, the unfolded state of the protein. This
is also known as the “all or none” transition in statistical thermodynamics. In such a
transition, the protein is either in the N state, with all residues in the n conformation or it is
in the U state, where all its residues are in the u conformation. The Gibbs free energy for
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this process is related to the equilibrium constant of this reaction by the following equation:
ΔG = −RT ln Keq. Keq is the ratio of the folding (kf) and unfolding (ku) rate constants. So,
Keq = kf/ku. When a disulfide bond is introduced into a protein, there is likely to be a
significant increase in free energy of U. The transition state (TS) can either (i) have a large
increase in its free energy similar to the unfolded state, in which case, the disulfide bond is
lost in the TS or (ii) have a negligible change in its free energy, in this case, TS is more N-
like and retains the disulfide bond.34 In (i), the folding rate does not change much, but the
unfolding rate decreases significantly. In (ii), the folding rate increases and the unfolding
rate remain constant. In any case, the ratio of kf/ku which is equal to Keq decreases, leading
to an increase in the free energy (ΔG) of the protein and making it conformationally more
stable. The assumption is that there is little or no difference in the enthalpies (ΔH) of the
disulfide-containing and reduced protein conformations. It has been proposed that the
decrease in the entropy of U can be predicted with the help of the following equation: ΔS =
−2.1 − (3/2)R ln n, where n is the number of residues in the loop formed by the
intramolecular disulfide bond.35 Similarly, reduction of a disulfide bond or mutation of
disulfide-forming Cys residues of a protein can result in increased entropy of U.
Consequently, Keq increases and ΔG of the protein decreases. This characteristic was
observed in the 110 residue starch-binding domain of Aspergillus Niger glucoamylase. The
wild-type protein (SBD) possesses a disulfide bond between C3 and C98, creating a 94
residue loop between its N-terminus and the short loop between its seventh and eighth β-
strands. Two different mutants C3G/C98G (GG) and C3S/C98S (SS) were constructed and
their stability compared to that of SBD by determining their unfolding temperature and other
thermodynamic parameters using DSC and CD techniques.36 The unfolding temperatures
were 10 °C lower for the mutants (43 °C) compared to wild type SBD (53 °C). The
unfolding processes for SBD, GG and SS were determined to be reversible with GG and SS
having about 10 kJ/mol free energy lower than SBD. The contribution of entropic
destabilization was much larger compared to that of the enthalpic destabilization.
When multiple disulfide bonds are introduced into a protein, they can act cooperatively to
stabilize the protein. The overall increase in the free energy of a protein in that case is higher
than the sum of the increases in free energies due to individual disulfide pairs. This
phenomenon is seen in the Bacillus circulans xylanase. When disulfide bonds were
introduced into it by the following mutations: S110C/N148C (DS1) and A1GC/G187,C188
(cX1), the overall increase in its free energy was 5.4 kcal/mol, 0.8 kcal/ mol more than the
sum of the free energy increases (4.6 kcal/mol) due to each mutation separately.
Consequently, the melting temperature of this double mutant was 12.4 °C, compared to the
5.0 °C and 3.8 °C increase in melting points in the DS1 and cX1 mutants.37
It is difficult to predict whether increasing conformational rigidity upon addition of a
disulfide bond will always improve the stability and/or activity of a protein. A good example
that illustrates the effect of the location of a disulfide on structural stability and enzymatic
activity was shown in T4 lysozyme. Four mutants of T4 lysozyme with a disulfide bond at
Cys9–Cys164, Cys21–Cys142, Cys90–Cys122, and Cys127–Cys154 were designed based
on molecular modeling experiments.38 The thermal stabilities of the oxidized mutants were
compared to their corresponding reduced mutants as well as to wild type T4 lysozyme. The
oxidized Cys9–Cys164 mutant has a melting temperature 6.4 °C higher than that of the wild
type while maintaining its enzymatic activity. In contrast, the Cys21–Cys142 mutant has the
best thermal stability but has no enzymatic activity. Finally, the Cys90–Cys122 and
Cys127–Cys154 mutants have lower thermal stabilities and enzymatic activities compared
to that of the wild type enzyme. In another case, Ser52, Ser53, Ser78, Ser79, and Ser80 in
alkaline phosphatase (AP) were mutated to the respective Cys residue; a disulfide bond was
formed between the new Cys residue and Cys67. All of the disulfide mutants had improved
thermal stability but lower enzymatic activities than that of the native AP.39 The decreased
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enzymatic activity of the mutant appeared to be due to the enhanced rigidity and lower
substrate affinity of the active site imposed by the disulfide bond which is located near the
residues. Thus, the location of the non-native disulfide bond affects the physicochemical
stability and biological properties of the mutant proteins in a manner difficult to predict.
To impose conformational rigidity, a disulfide bond has also been introduced in peptides to
form cyclic structures (cyclic peptides), which stabilizes specific secondary structures (i.e.,
β- and γ-turns). The formation of cyclic peptides in some cases enhances receptor-binding
affinity and selectivity, as shown in opioid peptides.40 Several cyclic peptides with a
disulfide bond have been marketed as therapeutic agents, including Integrilin®41,42 and
oxytocin (Pitocin®).43 Integrilin® is a cyclic Arg-Gly-Asp (RGD) peptide, which is used to
treat thrombosis; it binds selectively to gpIIb/IIa receptors on the surface of platelets, thus
blocking fibrinogen-mediated platelet aggregation.41,42 Cyclic peptides have also been
shown to be chemically and enzymatically more stable than their parent linear analogues.
The Asp-mediated chemical degradation of RGD peptides was suppressed by the formation
of a cyclic RGD peptide with a disufide bond; thus, the chemical stability of the cyclic RGD
peptide is higher than that of the parent linear form.15,44,45
We discussed above the increase in stability of SBD by creating its two mutants: GG and
SS. Earlier, a partly similar approach was taken to stabilize SBD. Two mutants were created
C3S and C3G. C3G and C3S both showed a 9 C decrease in the melting point of wild type
SBD. The explanation for this decreased stability was that the remaining unmutated C98 of
SBD was able to form dimers in the native state. Therefore, although addition of disulfide
bonds intramolecularly can help increase protein stability, formation of intermolecular
disulfide bonds can destabilize a protein.46
4. Analysis of Free Thiol and Disulfide Bond
The presence of a free thiol group in the Cys residues in a protein can be quantitatively
determined by different methods, including the use of malemide (i.e., ThioGlo),47 Ellman’s
reagent (5,5'-dithiobis-(2-nitrobenzoic acid) or DTNB),48–51 and bimane reagents (Figure
2).52,53 The presence of a disulfide bond can be detected using the crabescein reagent.54
Ellman’s reagent (DTNB) was the earliest reagent widely used for estimating the number of
thiol groups. The reaction between DTNB and thiol group(s) produces an equivalent amount
of 5-thio-2-nitrobenzoic acid, of which the absorbance can be measured at 412 nm. It was
found that the DTNB method could underestimate the concentration of thiol groups in a
protein due to its incomplete reaction.47,55 Addition of cytamine as an accelerator of the
DNTB-thiol reaction improves the accuracy of thiol determination (Figure 2a).51 As an
alternative reagent, 4,4'-dithiodipyridine (DTDP) has a performance similar to that of the
DTNB/cystamine in determining thiol concentrations (Figure 2a).51 Upon reaction with the
thiol group, DTDP releases 4-thiopyridine (4-TP), which absorbs at 342 nm. One drawback
to using DTDP is that some proteins have inherent absorbance at 342 nm, which can
interfere with the quantitative measurement of 4-TP. A new derivative of Ellman’s reagent,
n-octyl-5-dithio-2-nitrobenzoic acid (ODNB) has been designed; this reagent can react with
all thiol groups of a protein, including the buried ones, in a relatively short time (Figure
2a).55
Malemide derivatives are also used to determine the number of thiol groups in a protein.
ThioGlo® reagents (ThioGlo®1, λEx= 379 nm and λEm = 513 nm) are maleimide
derivatives of naphthopyranone fluorophores that emit fluorescence upon thiol alkylation
(Figure 2a). ThioGlo®1 is forty times more sensitive than DTNB and other maleimide
reagents. The protein-ThioGlo adduct does not require separation prior to quantitative
determination due to the low fluorescence of the starting reagent. One caution is that the
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reaction should not be carried out at a higher pH (>8) because of the possibility of amine
alkylation of the malemide and adduct degradation. Possible disadvantages include the low
water solubility of the ThioGlo reagent and the instability of protein-ThioGlo adducts, which
can lead to inaccuracy in the quantitative determination of the thiol group.
Bimane derivatives (i.e., monobromobimane (mBBr), dibromobimane (bBBr) and
monobromotrimethylammoniobimane (qBBr)) have also been developed for quantitative
determination of thiol group(s) of proteins in cells (Figure 2b). Bimane derivatives have no
intrinsic fluorescence; upon reaction with thiol groups in proteins, they become highly
fluorescent.52 Both mBBr and bBBr can be used to measure the total cellular thiol content
and qBBr can be used to measure the extracellular and membrane thiol content. Due to the
presence of charged group in qBBr, this molecule cannot permeate the cell membranes and
it can therefore be used to measure the extracellular thiols. mBBr can penetrate cell
membranes and react with thiols in the cells as well as the thiols in the extracellular space.
Thus, the difference in the thiol content measured by mBBr and qBBr gives the amount of
thiols inside the cells. One of the advantages of using these bimane derivatives is that they
are stable during exposure to air and irradiation as well as during general laboratory
procedures. Bimane has also been used to determine the intracellular levels of thioredoxin
after isolating the modified protein using an antibody affinity Sepahrose column. After
elution from the column, the amount of thioredoxin can be determined using a fluorescence
spectrometer.56
5. Degradation of Disulfide Bonds
Chemical degradation of disulfide bonds has been studied in both peptides and proteins with
most of the disulfide bond degradation observed under neutral and basic conditions (Figure
3).15,57 Degradation of disulfide bonds can be classified into three major pathways: (1)
direct attack on the sulfur atom by the hydroxyl anion, opening the disulfide bond to form
sulfenic acid/thiolate anion (Fig. 3a); (2) A β-elimination reaction in which the α-proton of
the Cys residue is abstracted (which produces dehydroalanine/persulfide (Figure 3b)); and
(3) the α-elimination caused by the hydroxyl ion attacking the β-proton of the Cys residue to
produce the thiolate/thioaldehyde (Figure 3c).58
The hydroxyl attack of the disulfide bond produces sufenic acid and thiolate anion (1, Figure
3a). The thiolate anion 1 can proceed to attack another disulfide bond on another protein
molecule to produce a thiolate dimer intermediate 2 (pathway a, Figure 3a). This
intermediate (2) undergoes three possible reactions as shown in pathways b, c, and d. In
pathway b, intramolecular nucleophilic attack of the sulfenic acid by the thiolate anion
produces dimer 3 with two intermolecular disulfide bonds. Intermediate 2 can form sulfenic
acid dimer 4 by abstracting a proton from water (pathway c). Higher molecular weight
oligomers such as trimer 5 can be produced via intermolecular disulfide bond reactions
utilizing pathway d. The thiolate anion 1 can also undergo an intermolecular reaction
between the sulfur atom of the sufinic acid group and a disulfide in another molecule to give
an intermediate dimer 6 as shown in pathway e. The resulting thiolate 6 oligomerizes by
reacting with another protein molecule to generate a trimer 7 (pathway f); further
intermolecular reactions lead to higher molecular weight oligomers. Intermediate 6 can also
form a dimer molecule with two free thiols (8).
The second degradation pathway is via β-elimination by hydroxyl anion abstraction of the
acidic Cα proton of Cys residue to yield a dehydroalanine-persulfide 9 (Figure 3b). The
disulfide bond can be reconnected by nucleophilic attack on the dehydroalanine by the
persulfide anion (pathway a, Figure 3b). The resulting products (10) form a racemic mixture
at the Cα of Cys residue (10, Figure 3b). The persulfide 9 can undergo a sulfur extrusion
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reaction via pathway b to yield the thiolate anion 11. The thiolate anion in 11 reacts with the
alkene functional group of the dehydroalanine to generate the thioether 12; this reaction can
also take place in an intermolecular fashion to produce oligomers. A similar reaction has
been observed in an IgG1 monoclonal antibody59 and cyclic peptides containing a disulfide
bond.15,57 In the IgG1, this thioether bond was observed at C233, which links the heavy
chain to the light chain.59 This modification was identified by LC-MS tandem mass
spectrometry. Abstraction of a proton from the solvent by the thiolate anion 11 produces
dehydroalanine-thiol 13. There is a possibility that the amino group from either the Lys or
the N-terminus of the protein may react with the alkene group of the dehydroalanine to
produce a secondary amine 14. This reaction has been observed as a degradation product of
cyclic peptides.15,57
Finally, the α-elimination reaction proceeds via the abstraction of the α-proton of the Cys
residue followed by disulfide bond breakage to produce thiolate /thioaldehyde 15 (Figure
3c). Protonation of the thiolate anion yields thiol-aldehyde 16 (pathway a). In the presence
of the hydroxyl anion, the thioaldehyde group can be converted to an aldehyde 18 via
intermediate 17 (pathway b). An amino group (i.e., Lys or N-terminus) that is in close
proximity to the aldehyde group in 18 may also produce an imine product 19. The imine
reaction may produce bimolecular reactions to create oligomers.
Intermolecular covalent bond reactions (disulfide, thioether, amine and imine in Figure 3)
producing oligomers which could lead to the association, aggregation and precipitation of
proteins. For example, intermolecular disulfide formation causes aggregation of nascent
thyroglobulin (Tg) protein. Monomeric Tg is a precursor to the synthesis of thyroid
hormone. It contains more than 100 Cys residues and can produce aggregates through the
formation of non-native intermolecular disulfide bonds due to the oxidizing environment in
the endoplasmic reticulum of thyroid cells.60 During the transport of Tg to the golgi
complex, the aggregates of Tg undergo disulfide reduction and dissociation to form
monomers with assistance from molecular chaperones. This suggests that the frequency of
Cys residues in the protein as well as the redox status of its environment are important
factors that contribute to its disulfide-mediated aggregation. Intermolecular disulfide bond
reactions in α- and β-crystallin induced by X-ray irradiation were shown to be partly
responsible for catarct formation in the rabbit eye lens. It is interesting to note that the
reaction between prednisolone and the amino group(s) of crystallin alters crystallin
conformation to expose the buried thiol groups.61,62 These exposed thiol groups then
undergo oxidation to form intermolecular disulfides, which cause protein aggregation and
precipitation.61 It was made clear in a subsequent study that the crystallin that underwent
conformation change on reaction with predisolone was α-crystallin.63 In most cases, the
disulfide bond can be reversed by reducing agents (i.e., DTT), and its formation can be
inhibited by metal complexing agents (i.e., EDTA), or removing metal ions. Intermolecular
disulfide bond formation has been suggested to induce the aggregation of BSA. EDTA,
citrate, and DTT have been shown to suppress the aggregation of BSA.64
6. Thiol Reaction and Derivatization
The thiol group in Cys can undergo oxidation reactions to form sulfenic (R-S-OH), sulfinic
(R-SO2H), and sulfonic (R-SO3H) derivatives as well as the disulfide bond. Thiol groups in
proteins are inherently very reactive and can participate in side reactions with reagents used
to manipulate other functional groups in a protein and the other solution components. The
presence of a free cysteine residue may cause unwanted intramolecular disulfide scrambling,
and covalent oligomerization via intermolecular disulfide formation. To prevent these
reactions, thiol groups can be derivatized with acetate, acetamide, 1,3-propane sultone65,
methyl methanethiosulfonate, methoxycarbonylmethyl disulfide66, maleimide,
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tetrathionates, and dinitrophenyl alkyl disulfides (DNPSSR)67 (Figure 4). Human serum
albumin, [Lys8] vasopressin, bovine insulin, and bovine pancreatic ribonuclease have been
alkylated with 1,3-propane sultone to increase their solubility and stability to acid
hydrolysis. Alkylating the free thiol of the tetanus toxoid with n-ethylmaleimide inhibits
moisture-induced aggregation of the lyophilized toxoid.68
To avoid side reactions of the Cys thiol group, Cys has frequently been mutated to Gly, Ala,
and Ser residues in proteins. The C6A, C111S and C6S/C111A mutants of human CuZn
dismutase (SOD) and the C6A mutant of bovine SOD showed greater resistance to loss of
enzymatic activity than did the respective native SODs upon thermal unfolding at 70 °C.69
This corresponds to the fact that the mutants can reversibly refold after denaturation while
the unfolded native SOD refolds incorrectly. Cys mutation studies have been used to
determine the role of free and disulfide-bonded Cys residues in the function of many
proteins. Meprins, cell surface and secreted metalloendopeptidases, are oligomers made up
of disulfide-linked multidomain subunits.
Mutations of C320A and C289A of mouse meprin-α both resulted in an increased
susceptibility to proteolytic degradation and heat deactivation. Although the mutants
retained their catalytic activity toward a bradykinin peptide, they displayed decreased
activity toward the protein substrate azocasein. It was found that the C320A mutant only
formed monomers, while the C289A mutant formed dimers and oligomers, suggesting that
Cys 320 but not C289 is involved in inter-subunit disulfide formation.70 Mutation of either
Cys residue resulted in a change in protein structure causing it to lose its enzymatic activity
toward a protein substrate. Thus, Cys mutation is a technique that can not only shed light on
the importance of the state of Cys residues (paired or reduced, intra- or interprotein pairing)
in a particular protein but can also help to distinguish the different roles of each Cys in the
protein.
The Cys residue of therapeutic proteins has also been PEGylated to improve their
physicochemical stability, pharmacokinetics and pharmacodynamics properties. PEGylated
proteins usually have lower glomerular filtration and immunogenicity. The molecular weight
of these PEG reagents can range from 2 to 50 kDa. The PEGylation of a Cys residue is more
selective than PEGylation of Lys residue. PEGylation of Lys residues gives a heterogenous
mixture of products with a distribution of conjugated products, which is difficult to control.
The site-specific PEGylation the Cys residue is normally carried out with PEG-Maleimide,
PEG-acrylamide, PEG-acrylate, PEG-vinyl sulfone, PEG-epoxide or PEG-iodoacetamide. In
a protein without a free thiol, a surface residue away from the active site can be mutated to a
Cys residue followed by PEGylation. This method has been successfully used to improve
the half-life of granulocyte colony stimulating factor (G-CSF)71 and the Q5C analog of
interferon-α (IFN-α)72, immunotoxin anti-Tac(Fv)-PE38 (LMB2),73 and Eryhtropoietin
(EPO).74 When LMB2 was stabilized by PEGylation using 5– or 20– kDa PEG-maleimide,
there was an increase in plasma stability (five- to eight- fold) and antitumor activity (three-
to four- fold).73 In this case, LMB2’s animal toxicity and immunogenecity were
significantly lower than that of the parent toxin. Native disulfide bond can also be
conjugated with PEG by reacting with PEG-monosulfone; the product forms a three carbon
bridge with the two sulfur atoms of the native disulfide bond. Interferon α-2b, anti-CD4+
antibody, and L-asparaginase have also been PEGylated in this manner. In the case of
interferon α-2b, the PEGylated product maintains its biological activity as well as its tertiary
structure, which was confirmed by NMR and X-ray crystallography.
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Thiol groups and disulfides have important roles in the stability and solubility of proteins.
Thiols and disulfides are inherently very reactive. Increased research is being devoted to
studying the role of thiols and disulfides in problems associated with protein molecules.
Studies have shown some disulfide bonds in proteins to be essential for either protein
stability and/ or activity. On the other hand, some non-native disulfide bonds in proteins are
a result of altered in vitro or in vivo conditions and are detrimental to protein stability and/
or activity. Various reagents have been designed to detect and quantify free thiols and
disulfides in proteins. The choice of the appropriate labeling agent should be made after
careful consideration since they all have advantages and disadvantages. Changes in native
thiol and/or disulfide content in proteins can be blocked by either the addition of appropriate
redox reagents or irreversible conjugation with various agents as described above. Mutation
of the Cys residue to another amino acid (i.e., Ser, Ala) can be an alternative strategy when
the residue is not essential to protein activity. Protein molecules are highly complex systems.
Our knowledge of the role of Cys residue in these macromolecular systems is continuously
expanding. It is hoped that the growing appreciation for the role of thiols and disulfides in
protein structure may lead to new methods to improve the success in formulating proteins as
therapeutic agents.
Preliminary work in Dr. Siahaan’s laboratory has shown that the protein EC1 forms
intermolecular disulfide bonds, piquing our interest into studying the effect of this disulfide
bond on EC1 stability. EC1 is the N-terminal domain of E-cadherin, a transmembrane
protein found in the adherens junctions in epithelial and endothelial cells. E-cadherin
functions as a homophilic cell adhesion molecule75 and the EC1 domain has been suggested
to have a role in the intercellular interactions of E-cadherin.76 EC1 contains a single Cys
residue near its N-terminus. Across the cadherin family, the N-terminus of the first domain
is implicated to form domain-swapped dimers. The first domain of only E-cadherin in the
cadherin family contains a Cys residue. The oxidation of this Cys residue leads to a covalent
dimer formation and subsequent physical oligomerization of EC1. We, therefore, propose to
study the effect of EC1 dimerization and oligomerization on its structure and stability.
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Increasing trend in the use of recombinant proteins and monoclonal antibodies as drugs. The
number of new biotech drugs and new indications approved for biotech drugs from 1982 to
2005.
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Various labeling reagents for the detection and quantification of protein thiols and
disulfides. (a) Labeling protein thiols with 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB or
Ellman’s reagent), 4,4'-dithiodipyridine (DTDP), n-octyl-5-dithio-2-nitrobenzoic acid
(ODNB), and ThioGlo®1. (b) Labeling cellular protein thiols with bimanes:
monobromobimane (mBBr) and dibromobimane (bBBr) label thiols inside cells as well as
on cell surfaces, whereas monobromotrimethylammoniobimane (qBBr) labels only the cell
surface protein thiols.
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Degradation reactions of protein disulfide bonds in neutral and basic conditions. (a) Direct
attack on sulfur atom by hydroxyl anion, (b) β-elimination reaction, and (c) α-elimination
reaction.
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Reagents for derivatization of free thiols in proteins.
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